Therapeutic Asset Ratings
462 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Gnc-035
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Gnc-039
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
Gnc-077
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
gs-4528
Neoplasm
Gilead Sciences
P1
C
(36)
Gtb-5550
Neoplasm
Masonic Cancer Center, University of Minnesota
P1
C
(36)
Hbi-2376
Neoplasm
HUYABIO International, LLC.
P1
C
(36)
Hbi-2438
Neoplasm
HUYABIO International, LLC.
P1
C
(36)
hdm2020
Neoplasm
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
P1
C
(36)
Hemay181
Neoplasm
Ganzhou Hemay Pharmaceutical Co., Ltd
P1
C
(36)
hg146
Neoplasm
HitGen Inc.
P1
C
(36)
hh160
Neoplasm
Huahui Health
P1
C
(36)
Hlx 208
Neoplasm
Shanghai Henlius Biotech
P1
C
(36)
Hpv-T
Neoplasm
BGI, China
P1
C
(36)
hs-20117
Neoplasm
Hansoh BioMedical R&D Company
P1
C
(36)
Hs-It101
Neoplasm
Qingdao Sino-Cell Biomedicine Co., Ltd.
P1
C
(36)
Imgs-001
Neoplasm
ImmunoGenesis
P1
C
(36)
Imiquimod
Neoplasm
Toray Industries, Inc
P1
C
(36)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Neoplasm
Tianjin Medical University Second Hospital
P1
C
(36)
Immunoglobulin G1, anti-(human sialic acid-binding Ig-like lectin 15) (human monoclonal PYX-106 ?1-chain), disulfide with human monoclonal PYX-106 ?-chain, dimer
Neoplasm
Pyxis Oncology, Inc
P1
C
(36)
inp12
Neoplasm
InnoUp Farma S.L.
P1
C
(36)
Ivaltinostat
Neoplasm
Machaon Biotherapeutics, Inc.
P1
C
(36)
Jbz-001
Neoplasm
Jabez Bioscience, Inc
P1
C
(36)
Jsi-1187
Neoplasm
JS InnoPharm, LLC
P1
C
(36)
jyb1907
Neoplasm
Jemincare
P1
C
(36)
jzp815
Neoplasm
Jazz Pharmaceuticals
P1
C
(36)
Showing 326 to 350 of 462 assets
Previous
Page 14 of 19
Next
